Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
Cost-effectiveness of interferon/ribavirin treatment among nonresponders to initial interferon therapy for chronic hepatitis C. Kim, W. R., Poterucha, J. J., Dickson, E. R., Gross, J. B. W B SAUNDERS CO. 1998: 231A
View details for Web of Science ID 000076258100277